Medicure Inc (MCUJF) 1.9240 $MCUJF
Medicure Reports Financial Results for the First Quarter of 2015
CNW Group - Wed Apr 29, 6:11PM CDT
Medicure Inc. ("Medicure" or the "Company"

(TSXV:MPH, OTC:MCUJF), a specialty pharmaceutical company, today reported its results from operations for the first quarter ended March 31, 2015.
MPH.VN: 2.360 (-0.040)
Medicure Q1 Results and Conference Call Dates
PR Newswire - Mon Apr 27, 12:32PM CDT
Medicure Inc. ("Medicure" or the "Company"

(TSXV:MPH, OTC:MCUJF), a specialty pharmaceutical company, today announced that it will release financial results for the first quarter after market close on Wednesday April 29, 2015. Medicure will hold a conference call regarding the results on Thursday April 30, 2015 at 8:00 am, Central Time. (9:00 am, Eastern Time).
MPH.VN: 2.360 (-0.040)
Medicure Announces Approval of Expanded Dosing Time For AGGRASTAT®
PR Newswire - Thu Apr 23, 10:14AM CDT
FDA Approves Labeling Supplement
MPH.VN: 2.360 (-0.040)
Medicure to present at the 2015 Bloom Burton & Co. Healthcare Conference
CNW Group - Wed Apr 22, 10:14AM CDT
Medicure Inc. ("Medicure" or the "Company"

(TSXV:MPH, OTC:MCUJF), a specialty pharmaceutical company, today announced that the Company's President and Chief Operating Officer, Dawson Reimer, will present an overview of the Company at the 2015 Bloom Burton & Co. Healthcare Investor Conference at the Sheraton Centre Toronto Hotel on May 5, 2015 at 11:30 a.m. Eastern Time.
MPH.VN: 2.360 (-0.040)
Medicure reports financial results for the seven months ended December 31, 2014
PR Newswire - Tue Apr 14, 10:35AM CDT
Medicure Inc. ("Medicure" or the "Company"

(TSXV:MPH, OTCQB:MCUJF), a specialty pharmaceutical company, today reported its results from operations for the seven months ended December 31, 2014.
MPH.VN: 2.360 (-0.040)
Medicure announces grant of options
CNW Group - Fri Mar 27, 2:49PM CDT
Medicure Inc. (the "Company"

(TSXV:MPH, OTCQB:MCUJF) announces today that its Board of Directors has approved the grant of an aggregate of 236,070 options to certain directors, officers, employees, management company employees and consultants of the Company pursuant to the Company's Stock Option Plan. Of these options, 181,070 are set to expire on the tenth anniversary of the date of grant, 5,000 are set to expire on the third anniversary of the date of grant and 50,000 are set to expire on the first anniversary of the date of grant. All of the options were issued at an exercise price of $1.90 per share. The options are subject to the approval of the TSX Venture Exchange.
MPH.VN: 2.360 (-0.040)
Medicure announces issuance of shares under previously announced shares for debt settlement
PR Newswire - Fri Mar 20, 4:00PM CDT
Medicure Inc. (the "Company"

(TSXV:MPH, OTC:MCUJF.US) announces today that the Company has issued 108,206 of its common shares at a deemed price of $1.44 per common share extinguishing $155,816.64 of amounts owing to certain members of the Board of Directors and a consultant under shares for debt agreements originally entered into and announced on January 27, 2015. These shares will be subject to resale restrictions for a period of four months from the date of issuance under applicable securities legislation.
MPH.VN: 2.360 (-0.040)
Medicure provides quarterly revenue on a calendar basis following change to year end
PR Newswire - Mon Feb 02, 9:00AM CST
Medicure Inc. ("Medicure" or the "Company"

(TSXV:MPH, OTCQB:MCUJF), a specialty pharmaceutical company, today provided detail on its historic calendar quarter revenue in anticipation of future reporting under the new financial reporting periods. This change in year end from May 31 to December 31 was previously announced on December 18, 2014.
MPH.VN: 2.360 (-0.040)
Medicure announces shares for debt settlements
PR Newswire - Tue Jan 27, 3:16PM CST
Medicure Inc. (the "Company"

(TSXV:MPH, OTC:MCUJF.US) announces today that the Company, subject to all necessary regulatory approvals, has entered into shares for debt agreements with certain members of the Board of Directors and a consultant, pursuant to which the Company will issue 108,206 of its common shares at a deemed price of $1.44 per common share to satisfy $155,816.64 of outstanding amounts owing to these individuals. These settlements do not include Dr. Albert Friesen, Chair and Chief Executive Officer of the Company. The shares will be subject to resale restrictions for a period of four months from the date of issuance under applicable securities legislation.
MPH.VN: 2.360 (-0.040)
Medicure Announces Change in Fiscal Year End and Provides One-Time Guidance on Quarterly Revenue
PR Newswire - Thu Dec 18, 12:24PM CST
Medicure Inc. ("Medicure" or the "Company"

(TSXV:MPH, OTCQB:MCUJF), a specialty pharmaceutical company, today announced that the Board of Directors has approved a change in the Company's fiscal year end to December 31. The change will result in a stub period from June 1, 2014, to December 31, 2014, and as a result of the change, the first full fiscal year will end on December 31, 2015. This change in year end from May 31 to December 31 is being made by the Company to better align the Company's financial reporting calendar with its industry peers and with most other companies trading on the TSX.V.
MPH.VN: 2.360 (-0.040)